Mitora™17-DMAG is a high-purity HSP90 inhibitor and research-grade senolytic compound, widely used in cellular senescence, oncology, and protein homeostasis studies. 17-DMAG selectively inhibits HSP90 chaperone proteins, promoting senescent cell clearance and apoptosis in preclinical models. Our product is designed for B2B distributors, research laboratories, and academic institutions, ensuring reliable and reproducible results.
As a trusted senolytic compound supplier, Mitora™provides 17-DMAG – Premium HSP90 Inhibitor in bulk to research teams and distributors worldwide. Our rigorous quality control, consistent production, and international shipping ensure researchers have access to high-quality compounds for critical studies.
Copyright©2023 Mitora™
Powered by Mitora™